Evidence map›Paper›PMID 35254446›Full record

ArticleFEMS microbiology reviews2022

Expanding natural transformation to improve beneficial lactic acid bacteria.

Stefano Di Giacomo, Frédéric Toussaint, Laura Ledesma-García, Adrien Knoops, Florence Vande Capelle, Christophe Fremaux, Philippe Horvath, Jean-Marc Ladrière, Hassina Ait-Abderrahim, Pascal Hols and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in FEMS microbiology reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Isolation ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Stefano Di GiacomoBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-2609-2578
Frédéric ToussaintBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-4869-4350
Laura Ledesma-GarcíaBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0003-3276-2192
Adrien KnoopsBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-6250-906X
Florence Vande CapelleBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0003-1520-3903
Christophe FremauxHealth and Biosciences, IFF Danisco France SAS, CS 10010, F-86220 Dangé-Saint-Romain, France.ORCID 0000-0002-3894-1477
Philippe HorvathHealth and Biosciences, IFF Danisco France SAS, CS 10010, F-86220 Dangé-Saint-Romain, France.ORCID 0000-0003-2015-8123
Jean-Marc LadrièreHealth and Biosciences, IFF Danisco France SAS, CS 10010, F-86220 Dangé-Saint-Romain, France.ORCID 0000-0001-8674-9204
Hassina Ait-AbderrahimLesaffre, 137 Rue Gabriel Péri, 59700 Marcq-en-Barœul, France.ORCID 0000-0001-6347-8835
Pascal HolsBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0001-8749-3650
Johann MignoletBiochemistry and Genetics of Microorganisms (BGM), Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Croix du Sud 4-5, (box L7.07.06), B-1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-3721-4307
UCLouvain · BELesaffre (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, the growing human population exacerbates the need for sustainable resources. Inspiration and achievements in nutrient production or human/animal health might emanate from microorganisms and their adaptive strategies. Here, we exemplify the benefits of lactic acid bacteria (LAB) for numerous biotechnological applications and showcase their natural transformability as a fast and robust method to hereditarily influence their phenotype/traits in fundamental and applied research contexts. We described the biogenesis of the transformation machinery and we analyzed the genome of hundreds of LAB strains exploitable for human needs to predict their transformation capabilities. Finally, we provide a stepwise rational path to stimulate and optimize natural transformation with standard and synthetic biology techniques. A comprehensive understanding of the molecular mechanisms driving natural transformation will facilitate and accelerate the improvement of bacteria with properties that serve broad societal interests.

Indexed as

LactobacillalesAnimalsHumansLactobacillusbioengineeringcompetenceindustrial strainslactic acid bacteriaLactobacillusLactococcusnatural transformationStreptococcus

Identifiers

PMID35254446
PMCPMC9300618
OpenAlexW4214665357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.